Sistema de Información Esencial en Terapéutica y Salud


Última actualización: 20/2/2019
SIETES contiene 92669 citas

 1 a 20 de 135 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Cool C, Cestac P, McCambridge C, Rouch L, de Souto Barreto P, Rolland Y, Lapeyre-Mestre M. Reducing potentially inappropriate drug prescribing in nursing home residents: effectiveness of a geriatric intervention. Br J Clin Pharmacol 2018;84:julio. [Ref.ID 102880]
3.Enlace a cita originalTiene citas relacionadas Cita con resumen
Guirguis-Blake JM, Michael YL, Perdue LA, Coppola EL, Beil TL. Interventions to prevent falls in older adults. Updated evidence report and systematic review for the US Preventive Services Task Force. JAMA 2018;319:24 de abril. [Ref.ID 102686]
4.Enlace a cita originalTiene citas relacionadas Cita con resumen
5. Cita con resumen
Rosich Martí I, Allepuz A, Rodríguez Palomar G, Ortin Font F, Soler Cera M. Impact of an intervention on the prescription of aliskiren after new evidence on safety reported. Pharmacoepidemiol Drug Saf 2017;26:91-6. [Ref.ID 101949]
6. Cita con resumen
Kesselheim AS, Donneyong M, Dal Pan GJ, Zhou EH, Avorn J, Schneeweiss S, Seeger JD. Changes in prescribing and healthcare resource utilization after FDA Drug Safety Communications involving zolpidem-containing medications. Pharmacoepidemiol Drug Saf 2017;26:712-21. [Ref.ID 101627]
7. Cita con resumen
Vieira ER, Palmer RC, Chaves PHM. Prevention of falls in older people living in the community. BMJ 2016;353:i1419. [Ref.ID 100325]
8. Cita con resumen
Wise J. Hip fracture audit may have saved 1000 lives since 2007. BMJ 2015;351:h3854. [Ref.ID 99390]
9. Cita con resumen
Robertson MC, Gillespie LD. Fall prevention in community-dwelling older adults. JAMA 2013;309:1406-7. [Ref.ID 95237]
10. Cita con resumen
Hurt RD, Weston SA, Ebbert JO, McNallan SM, Croghan IT, Kung J, Schroeder DR, Roger VL. Myocardial infarction and sudden cardiac death in Olmsted County, Minnesota, before and after smoke-free workplace laws. Arch Intern Med 2012;1721:1635-41. [Ref.ID 94149]
11.Enlace a cita original Cita con resumen
Hudson B, Zarifeh A, Young L, Wells JE. Patients' expectations of screening and preventive treatments. Ann Fam Med 2012;10:495-502. [Ref.ID 93236]
12. Cita con resumen
Berwanger O, Guimaraes HP, Laranjeira LN, Cavalcanti AB, Kodama AA, Zazula AD, Santucci EV, Victor E, Tenuta M, Carvalho V, Mira VL, Pieper KS, Weber B, Mota LH, Peterson ED, Lopes RD, for the BRIDGE-ACS Investigators. Effect of a multifaceted intervention on use of evidence-based therapies in patients with acute coronary syndromes in Brazil: The BRIDGE-ACS randomized trial. JAMA 2012;307:2041-9. [Ref.ID 93066]
13.Tiene citas relacionadas Cita con resumen
Avery AJ, Rodgers S, Cantrill JA, Armstrong S, Cresswell K, Eden M, Elliott RA, Howard R, Kendrick D, Morris CJ, Prescott RJ, Swanwick G, Franklin M, Putman K, Boyd M, Sheikh A. A pharmacist-led information technology intervention for medication errors (PINCER): a multicentre, cluster randomised, controlled trial and cost-effectiveness analysis. Lancet 2012;379:1310-9. [Ref.ID 92721]
14.Tiene citas relacionadas Cita con resumen
Schnipper JL, Rothschild JM. Improving medication safety. Lancet 2012;379:1278-80. [Ref.ID 92719]
15.Tiene citas relacionadas
Price MJ, Topol EJ. Standard- vs high-dose clopidogrel after percutaneous coronary intervention. In reply. JAMA 2011;305:2522. [Ref.ID 91335]
16.Tiene citas relacionadas
Patti G, Pasceri V, Di Sciascio G. Standard- vs high-dose clopidogrel after percutaneous coronary intervention. JAMA 2011;305:2521. [Ref.ID 91334]
17.Tiene citas relacionadas
Yeong YH, Park Y, Kim I-S. Standard- vs high-dose clopidogrel after percutaneous coronary intervention. JAMA 2011;305:2520. [Ref.ID 91333]
18.Tiene citas relacionadas
Gurbel PA, Tantry US. An initial experiment with personalized antiplatelet therapy. The GRAVITAS trial. JAMA 2011;305:1136-7. [Ref.ID 90423]
19.Tiene citas relacionadas Cita con resumen
Price MJ, Berger PB, Teirstein PS, Tanguay JF, Angiolillo DJ, Spriggs D, Puri S, Robbins M, Garratt KN, Bertrand OF, Stillablower ME, Aragon JR, Kandzari DE, Stinis CT, Lee MS, Manoukian SV, Cannon CP, Schork NJ, Topol EJ, for the GRAVITAS Investigators. Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention. The GRAVITAS randomized trial. JAMA 2011;305:1097-105. [Ref.ID 90422]
Seleccionar todas
 1 a 20 de 135 siguiente >>